A study of a test called ROCA for women who have a high risk of developing ovarian cancer (ALDO)

Overview

Cancer types:

Ovarian cancer

Status:

Results

Phase:

Other

Details

This study was for women who have changes (mutations) in the BRCA1 or BRCA2 gene. This means they have an increased risk of developing certain cancers, including ovarian cancer.

This study was open for people to join in 2018 and 2019. The team published the results in 2022.

Recruitment start: 5 August 2018

Recruitment end: 30 April 2019

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Adam Rosenthal

Supported by

Abcodia Ltd (now owned by GENinCode Plc)

University College London Hospitals NHS Foundation Trust

UCLH Cancer Collaborative

North Central London Cancer Alliance

Last reviewed: 8 February 2023

CRUK internal database number: 15881

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

Questions for your doctor

What to ask your doctor about clinical trials.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.